Literature DB >> 11533168

Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays.

Y Zhang1, B A Luxon, A Casola, R P Garofalo, M Jamaluddin, A R Brasier.   

Abstract

The Paramyxovirus respiratory syncytial virus (RSV) is the primary etiologic agent of serious epidemic lower respiratory tract disease in infants, immunosuppressed patients, and the elderly. Lower tract infection with RSV is characterized by a pronounced peribronchial mononuclear infiltrate, with eosinophilic and basophilic degranulation. Because RSV replication is restricted to airway epithelial cells, where RSV replication induces potent expression of chemokines, the epithelium is postulated to be a primary initiator of pulmonary inflammation in RSV infection. The spectrum of RSV-induced chemokines expressed by alveolar epithelial cells has not been fully investigated. In this report, we profile the kinetics and patterns of chemokine expression in RSV-infected lower airway epithelial cells (A549 and SAE). In A549 cells, membrane-based cDNA macroarrays and high-density oligonucleotide probe-based microarrays identified inducible expression of CC (I-309, Exodus-1, TARC, RANTES, MCP-1, MDC, and MIP-1 alpha and -1 beta), CXC (GRO-alpha, -beta, and -gamma, ENA-78, interleukin-8 [IL-8], and I-TAC), and CX(3)C (Fractalkine) chemokines. Chemokines not previously known to be expressed by RSV-infected cells were independently confirmed by multiprobe RNase protection assay, Northern blotting, and reverse transcription-PCR. High-density microarrays performed on SAE cells confirmed a similar pattern of RSV-inducible expression of CC chemokines (Exodus-1, RANTES, and MIP-1 alpha and -1 beta), CXC chemokines (I-TAC, GRO-alpha, -beta, and -gamma, and IL-8), and Fractalkine. In contrast, TARC, MCP-1, and MDC were not induced, suggesting the existence of distinct genetic responses for different types of airway-derived epithelial cells. Hierarchical clustering by agglomerative nesting and principal-component analyses were performed on A549-expressed chemokines; these analyses indicated that RSV-inducible chemokines are ordered into three related expression groups. These data profile the temporal changes in expression by RSV-infected lower airway epithelial cells of chemokines, chemotactic proteins which may be responsible for the complex cellular infiltrate in virus-induced respiratory inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11533168      PMCID: PMC114473          DOI: 10.1128/JVI.75.19.9044-9058.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  A plaque assay for respiratory syncytial virus.

Authors:  A L KISCH; K M JOHNSON
Journal:  Proc Soc Exp Biol Med       Date:  1963-03

2.  Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6.

Authors:  J G Mastronarde; B He; M M Monick; N Mukaida; K Matsushima; G W Hunninghake
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

3.  A new class of membrane-bound chemokine with a CX3C motif.

Authors:  J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

Review 4.  The molecular biology of leukocyte chemoattractant receptors.

Authors:  P M Murphy
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation.

Authors:  R Garofalo; M Sabry; M Jamaluddin; R K Yu; A Casola; P L Ogra; A R Brasier
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages.

Authors:  S Becker; J Quay; H S Koren; J S Haskill
Journal:  Am J Physiol       Date:  1994-03

7.  Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells.

Authors:  M Jamaluddin; R Garofalo; P L Ogra; A R Brasier
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.

Authors:  M L Everard; A Swarbrick; M Wrightham; J McIntyre; C Dunkley; P D James; H F Sewell; A D Milner
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

9.  Risk of primary infection and reinfection with respiratory syncytial virus.

Authors:  W P Glezen; L H Taber; A L Frank; J A Kasel
Journal:  Am J Dis Child       Date:  1986-06

10.  Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus.

Authors:  R Arnold; B Humbert; H Werchau; H Gallati; W König
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

View more
  108 in total

1.  Regulation of host cell transcriptional physiology by the avian pneumovirus provides key insights into host-pathogen interactions.

Authors:  Shirin Munir; Vivek Kapur
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  TAK1 regulates NF-ΚB and AP-1 activation in airway epithelial cells following RSV infection.

Authors:  Nilay Dey; Tianshuang Liu; Roberto P Garofalo; Antonella Casola
Journal:  Virology       Date:  2011-08-10       Impact factor: 3.616

3.  Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Authors:  Tao Peng; Swathi Kotla; Roger E Bumgarner; Kurt E Gustin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Selective Affinity Enrichment of Nitrotyrosine-Containing Peptides for Quantitative Analysis in Complex Samples.

Authors:  Yingxin Zhao; Yueqing Zhang; Hong Sun; Rosario Maroto; Allan R Brasier
Journal:  J Proteome Res       Date:  2017-07-17       Impact factor: 4.466

5.  Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus.

Authors:  Sean M O'Donnell; Geoffrey H Holm; Janene M Pierce; Bing Tian; Melissa J Watson; Ravi S Chari; Dean W Ballard; Allan R Brasier; Terence S Dermody
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 6.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.

Authors:  Sif Hansdottir; Martha M Monick; Nina Lovan; Linda Powers; Alicia Gerke; Gary W Hunninghake
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

8.  Disruption of the airway epithelial barrier in a murine model of respiratory syncytial virus infection.

Authors:  Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-29       Impact factor: 5.464

Review 9.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

10.  Respiratory Syncytial Virus Utilizes a tRNA Fragment to Suppress Antiviral Responses Through a Novel Targeting Mechanism.

Authors:  Junfang Deng; Ryan N Ptashkin; Yu Chen; Zhi Cheng; Guangliang Liu; Thien Phan; Xiaoling Deng; Jiehua Zhou; Inhan Lee; Yong Sun Lee; Xiaoyong Bao
Journal:  Mol Ther       Date:  2015-07-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.